DGX240517C100000
- 25.89
- 0.000.00%
Quest Diagnostics Newsroom
Quest Diagnostics To Go Ex-Dividend On July 8th, 2024 With 0.75 USD Dividend Per Share
May 17th - $Quest Diagnostics(DGX.US)$ is trading ex-dividend on July 8th, 2024. Shareholders of record on July 8th, 2024 will receive 0.75 USD dividend per share on July 22nd, 2024. The ex-divide
Express News | Quest Diagnostics Elects Robert B. Carter, Cio of FedEx Corporation, to Board of Directors
Argus Adjusts Price Target on Quest Diagnostics to $215 From $163, Keeps Buy Rating
Quest Diagnostics (DGX) has an average rating of outperform and price targets ranging from $136 to $160, according to analysts polled by Capital IQ.
Quest Diagnostics Declares $0.75 Dividend
Quest Diagnostics Keeps Quarterly Cash Dividend at $0.75 a Share, Payable on July 22 to Shareholders of Record on July 8
05:53 PM EDT, 05/15/2024 (MT Newswires) -- Quest Diagnostics Keeps Quarterly Cash Dividend at $0.75 a Share, Payable on July 22 to Shareholders of Record on July 8
Press Release: Quest Diagnostics Declares Quarterly Cash Dividend
Quest Diagnostics Declares Quarterly Cash Dividend PR Newswire SECAUCUS, N.J., May 15, 2024 SECAUCUS, N.J., May 15, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic inform
Argus Raises Quest Diagnostics' Price Target to $163 From $155
01:48 PM EDT, 05/15/2024 (MT Newswires) -- Argus Raises Quest Diagnostics' Price Target to $163 From $155 Price: 140.62, Change: +1.46, Percent Change: +1.05
Cheating on Workplace Drug Tests Hits a Record -- Update
By Joseph De Avila Workers are cheating on drug tests at the highest rate in more than 30 years, according to one of the U.S.'s largest drug-testing labs. The increase in tampered tests came from sa
Employers Struggle With Drug Test Policies Amid Varying State Laws, Cheating on Drug Tests Reaches 30-Year High
Cheating on drug tests among American workers has surged to its highest level in over 30 years, according to a lab report from Quest Diagnostics Inc (NASDAQ:DGX).The lab reported that approximately 31
Cheating on Workplace Drug Tests Hits a Record -- WSJ
By Joseph De Avila Workers are cheating on drug tests at the highest rate in more than 30 years, according to one of the U.S.'s largest drug-testing labs. The increase in tampered tests came from sa
Buy Rating Affirmed for Quest Diagnostics on Strong Earnings Visibility and Growth Prospects
Quest Diagnostics Said to Be Nearing Deal for Canada's Lifelabs
Lab Week 2024 - Javarus Smith
NORTHAMPTON, MA / ACCESSWIRE / May 13, 2024 / Quest Diagnostics Quest colleagues from coast-to-coast marked Lab Week 2024 with a week full of activities to celebrate our medical laboratory professiona
Quest Diagnostics Incorporated (NYSE:DGX) On An Uptrend: Could Fundamentals Be Driving The Stock?
Quest Diagnostics' (NYSE:DGX) stock up by 9.2% over the past three months. Given that stock prices are usually aligned with a company's financial performance in the long-term, we decided to investig
Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference
Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will...
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
Express News | Quest Diagnostics Inc: Pathai Will Continue to Support Its Biopharmaceutical Clients at Its Biopharma Lab
Express News | Quest Diagnostics Inc: Under Terms of Merger, Quest Will Buy Anatomic and Digital Pathology Laboratory Services of Pathai
Express News | Quest Diagnostics Inc: To Acquire Pathai Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements With PathAI
Transaction is part of wide-ranging collaboration to combine Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations to speed diagnosis, improve quality and reduce cost